Thomas R. Malek

Immunology and MicrobiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD”.

BLIMP-1 and CEACAM1 cooperatively regulate human Treg homeostasis and function to control xenogeneic GVHD

JCI Insight(2025)10.1172/jci.insight.183676

N/A

0.104DataRank · unranked

1 citations

Aixin Yu, Miloš Vujanac, Sabrina Copsel, Alejandro Moro, Luis Nivelo +8 more

Medical Treatment Can Unintentionally Alter the Regulatory T-Cell Compartment in Patients with Widespread Pathophysiologic Conditions

American Journal Of Pathology(2020)10.1016/j.ajpath.2020.07.012

N/A

0DataRank · unranked

9 citations

Thomas R. Malek, Robert B. Levy, Sabrina Copsel

High-dose IL-2/CD25 fusion protein amplifies vaccine-induced CD4+ and CD8+ neoantigen-specific T cells to promote antitumor immunity

Journal for ImmunoTherapy of Cancer(2021)10.1136/jitc-2021-002865

N/A

0DataRank · unranked

32 citations

Kathryn M LaPorte, Sunnie Hsiung, Alicia Santos Savio, Thomas R. Malek, Rosmely Hernandez

Robust IL-2-dependent antitumor immunotherapy requires targeting the high-affinity IL-2R on tumor-specific CD8+ T cells

Journal for ImmunoTherapy of Cancer(2023)10.1136/jitc-2022-006611

N/A

0DataRank · unranked

31 citations

Rosmely Hernandez, Alicia Santos Savio, Thomas R. Malek, Kathryn M LaPorte

Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.02.015

N/A

0DataRank · unranked

7 citations

Sabrina Copsel, Cameron S. Bader, Ying Ding, Dietlinde Wolf, Charles Cash +12 more

Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancer

Immunity(2024)10.1016/j.immuni.2024.02.001

N/A

0DataRank · unranked

135 citations

Kathryn M LaPorte, Thomas R. Malek, Acacia N. Shouse

Interleukin-2 receptor signaling acts as a checkpoint that influences the distribution of regulatory T cell subsets

iScience(2024)10.1016/j.isci.2024.111248

N/A

0DataRank · unranked

8 citations

Alejandro V. Villarino, Thomas R. Malek, Acacia N. Shouse

Notch1 blockade by a novel, selective anti-Notch1 neutralizing antibody improves immunotherapy efficacy in melanoma by promoting an inflamed TME

Journal of Experimental & Clinical Cancer Research(2024)10.1186/s13046-024-03214-5

N/A

0DataRank · unranked

4 citations

Varsha Thakur, Kathryn M LaPorte, Vijay S. Thakur, Brian Flores, Valentina Caicedo +8 more

The Role of Viruses in the Glioma Tumor Microenvironment: Immunosuppressors or Primers for Anti-Tumor Immunity?

Cancers(2025)10.3390/cancers17121984

N/A

0DataRank · unranked

1 citations

Jay Chandar, Muhammet Enes Gurses, Thomas R. Malek, Ashish H. Shah, Anna Hudson

Sustained IL-2R signaling of limited duration by high-dose mIL-2/mCD25 fusion protein amplifies tumor-reactive CD8+ T cells to enhance antitumor immunity

Cancer Immunology Immunotherapy(2020)10.1007/s00262-020-02722-5

N/A

0DataRank · unranked

15 citations

Kevin H. Toomer, Janika Põder, Alicia Santos Savio, Sunnie Hsiung, Thomas R. Malek +1 more

Growth of human regulatory CD4+ T cells is more tightly controlled than effector T cells due to distinctive molecular programming

iScience(2025)10.1016/j.isci.2025.112553

N/A

0DataRank · unranked

0 citations

Aixin Yu, Luis Nivelo, Zhen Gao, Yuguang Ban, Alejandro V. Villarino +2 more